Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
6h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
7h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
9h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
17h agoBuffalo Potash Files Annual Information Form and New Technical Report
18h agoIonik Announces 30-Day Extension of Senior Debt Facility
Astrazeneca Plc logo

Astrazeneca Plc

About

13,916.00GBX-90.00 -0.64%
Live at 20:37 GMT+00:00
Market Cap$289.82B
P/E Ratio28.04
Volume1.04M
Beta1.29
RSI48.66
Gross Margin74.31%
Health TechnologyPharmaceuticals: Major

Astrazeneca Plc — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026
May 18 2026
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
May 18 2026
AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer
May 14 2026
Imfinzi + EV improves EFS & OS in bladder cancer
May 1 2026
FDA ODAC vote on camizestrant in breast cancer

Community Chat

Ask AI

Try asking
6ix6ixAIEvents